Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection.
Thaiss CA, Levy M, Grosheva I, Zheng D, Soffer E, Blacher E, Braverman S, Tengeler AC, Barak O, Elazar M, Ben-Zeev R, Lehavi-Regev D, Katz MN, Pevsner-Fischer M, Gertler A, Halpern Z, Harmelin A, Aamar S, Serradas P, Grosfeld A, Shapiro H, Geiger B, Elinav E.
Science. 2018 Mar 23;359(6382):1376-1383. doi: 10.1126/science.aar3318. Epub 2018 Mar 8.
PMID:29519916
Emerging hybrid shigatoxigenic and enteropathogenic Escherichia coli serotype O80:H2 in humans and calves.
Mainil JG, Nakamura K, Ikeda R, Crombé F, Diderich J, Saulmont M, Piérard D, Thiry D, Hayashi T.
Molecular characterization of enteropathogenic Escherichia coli isolated from patients with gastroenteritis in a tertiary referral hospital of northeast India.
Roy S, Bhattacharjee B, Mazumder PB, Bhattacharjee M, Dhar D, Bhattacharjee A.
Indian J Med Microbiol. 2024 Jan-Feb;47:100535. doi: 10.1016/j.ijmmb.2024.100535. Epub 2024 Feb 15.
PMID:38350526
[Enteropathogenic Escherichia coli].
Kvittingen J.
Tidsskr Nor Laegeforen. 1966 Jul 1;86(13):977-80.
PMID:5338786
Enteropathogenic Escherichia coli O80:H2 in Young Calves with Diarrhea, Belgium.
Thiry D, Saulmont M, Takaki S, De Rauw K, Duprez JN, Iguchi A, Piérard D, Mainil JG.